Average weight loss in week 1 on Mounjaro: what the trial data actually shows

What the SURMOUNT-1 trial data say about early versus cumulative loss

The most detailed evidence on Mounjaro's weight-loss trajectory comes from SURMOUNT-1, a 72-week randomised trial involving 2,539 adults with obesity and no diabetes, published in the New England Journal of Medicine. The trial did not report week-one figures separately, and that is telling. Researchers measured meaningful outcomes at 16, 36 and 72 weeks, because the medicine's mechanism takes time to reach its full effect. By 72 weeks, participants on 15 mg tirzepatide had lost an average of around 20–21% of their body weight. Participants on 5 mg and 10 mg showed progressively smaller but still substantial reductions.

What this means for the first week is straightforward: the trial was not designed to track early days, and the results that drove NICE's recommendation of tirzepatide accumulated across months of dose titration. If you are looking at week one, you are looking at a small fraction of a medicine whose effects build gradually. The fuller picture of average Mounjaro weight loss across the complete course puts the opening week in its proper context.

What actually changes in the body during the first seven days

Tirzepatide activates both GIP and GLP-1 receptors, which slows gastric emptying and reduces appetite, the only dual-agonist weight-loss medicine licensed in the UK. In the first days, appetite suppression can begin quite quickly, and eating less means the body draws on glycogen stores in the liver and muscles. Glycogen holds water at roughly 3 g per gram, so as those stores reduce, the scales can drop by a kilogram or more in ways that have little to do with fat loss. Conversely, if GI side effects like nausea lead to less movement or fluid intake, weight can temporarily stay flat or even edge upward.

The practical upshot: what you see on the scales in week one reflects fluid balance, gut contents and glycogen far more than it reflects adipose tissue. Noticing visible weight loss on Mounjaro typically takes several weeks longer, once the dose reaches a therapeutically meaningful level and appetite reduction compounds over time.

A simple checking habit that steadies your early expectations

Weighing yourself every day in week one and watching the number bounce can feel dispiriting. A more reliable approach: pick one morning per week, weigh yourself before eating or drinking anything, ideally after using the bathroom, and log that single number. That is it. One data point a week removes most of the noise from water, sodium and digestive timing, and over four to eight weeks a genuine trend becomes visible. Average weekly weight loss across the Mounjaro course tends to accelerate as doses increase, so the week-one figure is rarely the week to measure yourself by.

The NHS medicines page on tirzepatide notes that side effects such as nausea, vomiting and diarrhoea are most common early in treatment and after dose increases, another reason the opening week can feel unsettled even before appetite changes translate into scale movement. Giving your body a few weeks at the starter dose before drawing conclusions is what the prescribing schedule is built around.

When to expect more meaningful progress, and what shapes it

For most people, the dose titration schedule means the first genuinely therapeutic dose is reached around weeks 5–8, after the prescriber has reviewed progress and moved beyond 2.5 mg. Weight loss then tends to build month by month rather than week by week. First-month Mounjaro results vary considerably depending on starting dose, starting weight, diet and activity, but SURMOUNT trial data consistently show the steepest rate of loss in the middle portion of the treatment course, not the opening days.

Factors that influence how quickly weight loss appears include: how much the appetite suppression affects your actual food intake, whether GI side effects are limiting normal eating, baseline insulin sensitivity, and lifestyle changes alongside treatment. None of those are fixed, which is why a prescriber's ongoing review matters throughout the course. If you are considering Mounjaro or want to understand what private treatment involves, our prescribers can assess whether it is suitable for your circumstances. How long Mounjaro takes to work depends on far more than the first seven days, that page walks through the full timeline with the same evidence base. When you feel ready to take the next step, checking your eligibility with our prescribers is free and takes only a few minutes.